Journal article · 2006 · Open access
How a well-grounded minimal important difference can enhance transparency of labelling claims and improve interpretation of a patient reported outcome measure
Health and Quality of Life Outcomes, 4(1), 69 · Published 27 September 2006 · DOI 10.1186/1477-7525-4-69
In brief
“How a well-grounded minimal important difference can enhance transparency of labelling claims and improve interpretation of a patient reported outcome measure” is a 2006 journal article by Jan Brożek and 2 co-authors, published in Health and Quality of Life Outcomes. OpenAlex counts 193 citations as of 22 November 2026, which puts it in the top 6% of works published in 2006 by citations. It is open access under a CC BY licence: the full text is free to read at Health and Quality of Life Outcomes.
- Citations
- 193
- Most cited in
- 2021 (16)
- Field-weighted impact
- 7.61
- References
- 66
- Authors
- 3
Abstract
The evaluation and use of patient reported outcome (PRO) measures requires detailed understanding of the meaning of the outcome of interest. The Food and Drug Administration (FDA) recently presented its draft guidance and view on the use of PRO measures as endpoints in clinical trials. One section of the guidance document specifically deals with advice about the use of the minimal important difference (MID) that we redefined as the smallest difference in score in the outcome of interest that informed patients or informed proxies perceive as important. The advice, however, is short, indeed much too short. We believe that expanding the section and making it more specific will benefit all stakeholders: patients, clinicians, other clinical decision makers, those designing trials and making claims, payers and the FDA. There is no "gold standard" methodology of estimating the MID or achieving the meaningfulness of clinical trial results based on patient reported outcomes. There are many methods of estimating the MID usually grouped into two distinct categories: anchor-based methods, that examine the relationship between scores on the target instrument and some independent measure, and distribution-based methods resorting to the statistical characteristics of the obtained scores. Estimation of an MID and interpretation of clinical trial results that present patient important outcomes is demanding but vital for informing the decision to recommend approve a given intervention. Investigators are encouraged to use reliable and valid methods to achieve meaningfulness of their results, preferably those that rely on patients to estimate what constitutes a minimal important, small, moderate, or large difference. However, acquiring the meaningfulness of PRO measures transcends beyond a concept of the MID and we advocate that dichotomizing the scores of patient-reported outcome measures facilitate interpretability of clinical trial results for those who need to understand trial results after a labelling claim has been granted. Irrespective of the strategy investigators use to estimate these values, from the individual patient perspective it is much more relevant if investigators report both the estimated thresholds and the proportion of patients achieving that benefit.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Brożek, J., Guyatt, G. H., & Schünemann, H. J. (2006). How a well-grounded minimal important difference can enhance transparency of labelling claims and improve interpretation of a patient reported outcome measure. Health and Quality of Life Outcomes, 4(1), 69. https://doi.org/10.1186/1477-7525-4-69
MLA 9
Brożek, Jan, et al. “How a well-grounded minimal important difference can enhance transparency of labelling claims and improve interpretation of a patient reported outcome measure.” Health and Quality of Life Outcomes, vol. 4, no. 1, 2006, p. 69. https://doi.org/10.1186/1477-7525-4-69.
Chicago
Brożek, Jan, Gordon Henry Guyatt, and Holger Jens Schünemann. 2006. “How a well-grounded minimal important difference can enhance transparency of labelling claims and improve interpretation of a patient reported outcome measure.” Health and Quality of Life Outcomes 4 (1): 69. https://doi.org/10.1186/1477-7525-4-69.
Harvard
Brożek, J., Guyatt, G. H. and Schünemann, H. J. (2006) ‘How a well-grounded minimal important difference can enhance transparency of labelling claims and improve interpretation of a patient reported outcome measure’, Health and Quality of Life Outcomes, 4(1), p. 69. doi:10.1186/1477-7525-4-69.
IEEE
J. Brożek, G. H. Guyatt, and H. J. Schünemann, “How a well-grounded minimal important difference can enhance transparency of labelling claims and improve interpretation of a patient reported outcome measure,” Health and Quality of Life Outcomes, vol. 4, no. 1, p. 69, 2006, doi: 10.1186/1477-7525-4-69.
BibTeX
@article{brozek2006well,
title = {{How a well-grounded minimal important difference can enhance transparency of labelling claims and improve interpretation of a patient reported outcome measure}},
author = {Brożek, Jan and Guyatt, Gordon Henry and Schünemann, Holger Jens},
journal = {Health and Quality of Life Outcomes},
year = {2006},
volume = {4},
number = {1},
pages = {69},
doi = {10.1186/1477-7525-4-69},
url = {https://doi.org/10.1186/1477-7525-4-69}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2017 | 14 | |
| 2018 | 10 | |
| 2019 | 13 | |
| 2020 | 15 | |
| 2021 | 16 | |
| 2022 | 3 | |
| 2023 | 9 | |
| 2024 | 5 | |
| 2025 | 5 | |
| 2026 | 3 |
Its field-weighted citation impact is 7.61: it has been cited 7.61 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
- minimal important difference
- patient-reported outcome measures
- FDA draft guidance
- anchor-based methods
- distribution-based methods
- clinical trial endpoints
Work with this paper
Most-cited papers in Mathematics
- Random ForestsLeo Breiman · Machine Learning · 2001 · 142,830 citations
- Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple TestingYoav Benjamini, Yosef Hochberg · Journal of the Royal Statistical Society Series B (Statistical Methodology) · 1995 · 113,923 citations
- Fitting Linear Mixed-Effects Models Using lme4Douglas M. Bates, Martin Maechler, Benjamin M. Bolker and 1 more · Journal of Statistical Software · 2015 · 100,328 citations
- The moderator-mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations.Reuben M. Baron, David A. Kenny · Journal of Personality and Social Psychology · 1986 · 95,866 citations
- Using multivariate statisticsBarbara Gerson Tabachnick, Linda S. Fidell · 1983 · 79,867 citations
Questions about this paper
How do I cite this paper in APA style?
Brożek, J., Guyatt, G. H., & Schünemann, H. J. (2006). How a well-grounded minimal important difference can enhance transparency of labelling claims and improve interpretation of a patient reported outcome measure. Health and Quality of Life Outcomes, 4(1), 69. https://doi.org/10.1186/1477-7525-4-69
How many times has this paper been cited?
193 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Health and Quality of Life Outcomes: sign in and open the PDF from this page.
Who wrote this paper?
Jan Brożek, Gordon Henry Guyatt, Holger Jens Schünemann.
What is the DOI of this paper?
10.1186/1477-7525-4-69, permanently at https://doi.org/10.1186/1477-7525-4-69. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.